COVID-19: Remdesivir Gets Conditional Approval by European Commission

Society | July 7, 2020, Tuesday // 12:11| Views: | Comments: 0
Bulgaria: COVID-19: Remdesivir Gets Conditional Approval by European Commission fiercepharma.com

The European Commission had given conditional approval for the use of antiviral remdesivir in severe COVID-19 patients following an accelerated review process, making it the region’s first therapy to be authorised to treat the virus, Reuters reports.

A conditional marketing authorisation is one of the EU regulatory mechanisms created to facilitate early access to medicines that fulfil an unmet medical need, the Commission said.

The move comes just a week after the European Medicines Agency (EMA) gave its go-ahead for the drug to be use in adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support.

It also comes just days after the company allocated nearly all of its supply of the antiviral to the United States over the next three months.

Remdesivir is believed to be most effective in treating COVID-19 patients earlier in the course of disease./Nova Tv

We need your support so Novinite.com can keep delivering news and information about Bulgaria! Thank you!

Society » Be a reporter: Write and send your article
Advertisement
Advertisement
Expats.bg All Are Welcome! Join Now!
Bulgaria news Novinite.com (Sofia News Agency - www.sofianewsagency.com) is unique with being a real time news provider in English that informs its readers about the latest Bulgarian news. The editorial staff also publishes a daily online newspaper "Sofia Morning News." Novinite.com (Sofia News Agency - www.sofianewsagency.com) and Sofia Morning News publish the latest economic, political and cultural news that take place in Bulgaria. Foreign media analysis on Bulgaria and World News in Brief are also part of the web site and the online newspaper. News Bulgaria